USD 1.68 Billion
Spasticity Treatment Market Size, Share, and Growth Analysis
Spasticity Treatment Market By Drug Class (GABA Agonist, Alpha-2 Adrenergic Agonists, Botulinum Toxins), By Route of Administration (Oral, Parenteral), By Indication, By End User, By Region -Industry Forecast 2025-2032
Report ID:
SQMIG35D2301 |
Region:
Global |
Published Date: May, 2025
Pages:
162
|Tables:
113
|Figures:
72
Format -
Spasticity Treatment Market Insights
Global Spasticity Treatment Market size was valued at USD 1.68 Billion in 2023 and is poised to grow from USD 1.54 Billion in 2024 to USD 2.44 Billion by 2032, growing at a CAGR of 8.02% in the forecast period (2025-2032).
The global spasticity treatment market growth is undergoing drastic changes led by the formation of new technologies and innovative strategies for treatment. Current statistics indicated by the Physicians Group LLC during December 2023 reveal that an estimated number of 12.0 million patients worldwide suffer from spasticity, showcasing the enormous size of the population to be treated. New physical therapy modalities, including robotic therapy, electrical stimulation therapies, and virtual reality-based therapy, have demonstrated high effectiveness for enhancing motor function and reducing spasticity in patients. The application of such advanced technologies is revolutionizing traditional treatment paradigms and optimizing patient outcomes across various healthcare environments.
Moreover, the industry is witnessing a surge in research activities and clinical trials focused on developing new modalities of treatment. Neurotech International, in January 2024, received approval from the Therapeutic Goods Administration (TGA) and the Human Research Ethics Committee (HREC) to launch a Phase I/II trial of NTI164 to treat cerebral palsy spasticity. The step is an exhibition of the commitment of the sector to evidence-based practice and to innovation. Recent studies have shown that over 77% of cerebral palsy children have the spastic type, and this underscores the need for continued research and development in this therapeutic market.
Market snapshot - 2025-2032
Global Market Size
Largest Segment
Oral
Fastest Growth
Parenteral
Growth Rate
8.02% CAGR
Global Spasticity Treatment Market ($ Bn)
Country Share for North America (%)
To get more reports on the above market click here to Buy The Report
Spasticity Treatment Market Segments Analysis
The global spasticity treatment market is segmented into drug class, indication, route of administration, end user, and region. By drug class, the market is classified into GABA agonist, alpha-2 adrenergic agonists, and botulinum toxins. Depending on indication, it is divided into multiple sclerosis (MS), cerebral palsy (CP), and traumatic brain injury (TBI). According to route of administration, the market is bifurcated into oral and parenteral. On the basis of end user, it is categorized into pediatrics and adults. As per region, it is analyzed across North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.
Why Are GABA Agonists Leading the Spasticity Treatment Market in 2024?
As per the 2024 global spasticity treatment industry analysis, the GABA agonist segment has dominated the market with approximately 37% market share. The primary cause of such a high market share is the increasing adoption of GABA receptor agonists as spasticity treatments and their excellent therapeutic effects. Supernus Pharmaceuticals ramped up its clinical development of SPN-817, a novel GABA receptor modulator for the treatment of neurological disorders such as spasticity, in January 2024. The company highlighted promising preclinical results supporting greater efficacy and fewer side effects compared to conventional oral baclofen. Expansion in the segment is further complemented by exhaustive studies establishing the effectiveness of GABA agonists in treating neurological complications arising from spasticity.
A large portion of the global spasticity treatment market share consists of botulinum toxins, which provide targeted and effective relief through the intramuscular injection administration, which is administered locally. The mechanism of action of such toxins is that they block the release of acetylcholine at the neuromuscular junction, thus causing a decrease in muscle hyperactivity and increased motor control. As they are minimally invasive and their effects last for a long duration of time, both doctors and patients utilize them very extensively.
What Drives the Continued Growth of Oral Treatments for Generalized Spasticity?
Based on the 2024 global spasticity treatment market forecast, the oral segment remains the largest in the market, holding approximately 52% of the total market share in 2024. This dominance is on the basis of the extensive usage and convenience associated with oral medications for spasticity management. Oral formulations like Baclofen, clonidine, and Tizanidine and anticonvulsants like benzodiazepines and gabapentin are very much in vogue due to the cost factor and for ease of consumption. Current trends like the availability of new oral products and sustained-release products leading to increased compliance by patients along with greater benefits are further propelling the leaders of the segment. Oral medications are typically preferred by healthcare providers as the first initial first-line treatment option for the management of spasticity, particularly in cases of generalized spasticity that require systemic treatment modalities.
The parenteral segment is predicted to emerge as the fastest-growing segment of the market and is anticipated to achieve approximately 8% CAGR from 2025 to 2032. The high growth is triggered by the increasing use of botulinum toxin injections and intrathecal Baclofen treatment in managing cases of severe spasticity. The segment has growth aided by clinical studies demonstrating superior therapeutic outcome of parenteral administration when oral treatment fails.
Global Spasticity Treatment Market By Route of Administration
To get detailed analysis on other segments, Request For Free Sample Report
Spasticity Treatment Market Regional Insights
Why Is North America Leading the Global Spasticity Treatment Market?
North America is the dominant player in the spasticity treatment market, driven by advanced healthcare infrastructure and increasing research and development activities. The region has the backing of well-established reimbursement policies and the dominant market presence of major players. The United States has a strong hold in the regional market, followed by Canada and Mexico. Each country contributes uniquely to the growth of the market through different healthcare measures and treatment accessibility programs. The regional market is characterized by high adoption rates for new treatments and increasing awareness of drug options available for spasticity.
US Spasticity Treatment Market Trends
The US has a leadership position in the North American spasticity treatment market, holding approximately 41% market share in 2024. Leadership in the country is complemented by increasing research investment in multiple sclerosis (MS) and advancements in advanced drug delivery solutions. The presence of cutting-edge healthcare infrastructure and favorable reimbursement policies contributes to the market strength. The country has experienced a significant advancement in the lines of treatment, particularly botulinum toxin treatment and intrathecal baclofen delivery systems. Active attitude of the FDA toward approving new treatments and access by big pharma companies enable the market to grow.
Canada Spasticity Treatment Market Trends
The Canadian spasticity treatment sector is steadily growing because of mounting awareness of neurological disease and an aging Canadian population. Early treatment and availability of such therapies as GABA agonists, botulinum toxin injections, and intrathecal baclofen pumps are all such programs supported by Canada's health care system. Canadian research facilities are also actively involved in clinical trials and studies, which are contributing to the development of new methods for spasticity management and improving the level of access to therapy across the country.
What Factors Are Fueling the Demand for Spasticity Therapies Across Europe?
The spasticity treatment market in Europe highlights a robust framework based on advanced healthcare systems and strong research programs. The regional market is characterized by an efficient healthcare delivery system throughout Germany, the United Kingdom, France, Italy, and Spain. Each of these nations significantly contributes to the market through differing treatment access strategies and reimbursement schemes. The country has good coordination among healthcare professionals, research institutions, and drug companies, which propels innovation in spasticity drugs.
Germany Spasticity Treatment Market Trends
Germany is the largest market in Europe for the treatment of spasticity and controls an estimated 23% of the market share in the region as of 2024. The country's market leadership is supported by strong healthcare infrastructure and universal insurance coverage system. German healthcare professionals have shown significant adoption of new spasticity treatment modalities, particularly in the areas of botulinum toxin therapy and new drug delivery technologies. The nation's strong emphasis on research and development, in addition to its well-established regulatory framework for managing spasticity, continues to be a propellant for market growth.
France Spasticity Treatment Market Trends
France enjoys the highest growth opportunity in the European market, with the anticipated CAGR of approximately 9% for 2025-2032. The nation's healthy growth trajectory is supported by its high priority on healthcare innovation and increasing R&D activity on spasticity treatment. France's healthcare system's patient accessibility focus, and treatment effectiveness are a significant cause of the market growth. The country has been robust in creating and enforcing new treatment guidelines and maintaining high rates of patient care in the management of spasticity.
UK Spasticity Treatment Market Trends
As a result of its well-established healthcare infrastructure and robust clinical research capacity, the United Kingdom (UK) has become a developed market for receiving treatment for spasticity in Europe. Oral, injectable, and implantable drugs for neurological diseases are covered by the National Health Service (NHS), which strives to make such treatments accessible on a large scale. There has also been an increase in the number of clinical trials and approvals for spasticity drugs by regulatory bodies in the United Kingdom. This has helped in market growth and driven innovation in patient-focused, non-invasive treatment options.
Why Is Asia-Pacific the Fastest-Growing Region in the Spasticity Treatment Market?
Asia-Pacific presents an energetic market culture for spasticity treatment with high-speed building of healthcare facilities and increased cognition of neurological illnesses. It presents diversified markets such as China, Japan, India, Australia, and South Korea, with respective unique healthcare infrastructure and treatment styles. The demand is driven by improved access to healthcare, rising healthcare expenditures, and increasing applications of advanced treatment modalities. The region's huge patient population and increasing investments in healthcare create enormous market growth prospects.
China Spasticity Treatment Market Trends
China is the market leader of the Asia-Pacific spasticity treatment market, indicating strong market presence through its extensive network of healthcare and gigantic patient population. The country's market leadership is supported by government initiatives to improve accessibility of healthcare and extensive investment in healthcare infrastructure. China's focus on establishing indigenous capacity for spasticity treatment product production and expanding healthcare coverage has strengthened its market position. The country's large population base and improving healthcare awareness are the reasons that give its market dominance.
Japan Spasticity Treatment Market Trends
Japan enjoys the most significant growth trajectory in the Asia-Pacific market, driven by its advanced healthcare system and aging population. The superiority of the country's healthcare infrastructure and heavy focus on cutting-edge treatment modalities enable market development. Japan's research and development focus in neurological treatments, and its aging population makeup, ensure an environment for market development. The country's health policies and prioritization of quality delivery of care continue to drive market development.
Global Spasticity Treatment Market By Geography
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Spasticity Treatment Market Dynamics
Spasticity Treatment Market Drivers
More Individuals Afflicted with Neurological Conditions
- Among the most significant drivers of growth in the spasticity treatment market is the growing prevalence of neurological diseases such as cerebral palsy, multiple sclerosis, and stroke-induced spasticity. Against the backdrop of the growing incidence of these disorders across the globe, there is a growing demand for effective treatments like oral drugs, physical therapy, and botulinum toxins, which is fueling the growth of the market.
Advances in Pharmaceutical Research and New Drug Development
- The growth of the market is driven by continuous innovations in the discovery of new pharmacological drugs. These innovations are selective GABA agonists, gene therapy, and newer formulations for botulinum toxin. Researching custom pharmaceuticals and targeted therapies has the potential to improve treatments, which will also raise the number of individuals who use novel therapy for spasticity.
Spasticity Treatment Market Restraints
High Treatment Cost
- Patients can have limited access to treatments because of the high cost of spastic treatments, especially more sophisticated ones like botulinum toxin injections and physical therapy. This is particularly the case in areas with low incomes. The reason that these treatments are less affordable because of insurance coverage caps and out-of-pocket costs is yet another reason why the industry cannot grow.
Undesirable Effects of Spasticity Treatments
- Several treatments for spasticity, such as the drugs Baclofen and Tizanidine, and botulinum toxin injections, produce significant side effects like a deficiency in muscular strength, drowsiness, or with the respiratory system. Patients would perhaps be discouraged from seeking long-term treatment due to the unwanted effects, which would prevent the market from growing.
Request Free Customization of this report to help us to meet your business objectives.
Spasticity Treatment Market Competitive Landscape
The global spasticity treatment market is highly competitive, with prominent players focusing sharp attention on improving product portfolios and patient outcomes. Companies are investing in and developing new therapies, mainly in the form of oral medications or botulinum toxin-based treatments. Most major firms on the market go for strategic partnerships, acquisitions, and regional expansions in their efforts to position themselves in the industry.
- NeuroRestore (US, 2018): New neurostimulation approaches will be developed by NeuroRestore aimed at managing patients with spasticity and other movement disorders. Currently, the company develops an invasive neurostimulation device for curing spasticity, where it is a manifestation of neurological diseases such as cerebral palsy and stroke, and improving mobility in patients with this condition. It can also be incorporated in existing treatment regimens, thus creating a more individual treatment regimen.
- Neurosteer (Israel, 2015): Neurosteer plans to develop wearable devices for administering neurostimulation without moving the patient's body for personalized treatments against neurological disorders such as spasticity. The device can deliver real-time brain imaging, thus, enabling it to distinguish normal from abnormal activities in the brain and analyze the impact of treatment.
Top Player’s Company Profile
- Allergan
- Ipsen
- Merz Pharmaceuticals
- Zambon
- Teva Pharmaceutical Industries
- AbbVie
- Mylan N.V.
- UCB Pharma
- Medtronic
- Novartis
- Mallinckrodt Pharmaceuticals
- Bausch Health
- Lundbeck
- Amgen
- Sanofi
Recent Developments in Spasticity Treatment Market
- Swissmedic approved Merz in June 2024 to use XEOMIN (incobotulinumtoxinA) to treat focal spasticity of the lower limb. Aside from the permissions already awarded for spasticity of the upper limb, this expansion provides an opportunity for Swiss patients to access treatment options that are more holistic.
- The findings of the AboLiSh study, in which Dysport (abobotulinumtoxinA) efficacy in treating spasticity was proven, were released by Ipsen in January 2024. Additional evidence for the usefulness of Dysport as a first-line treatment method for spasticity management was established by the results, given at the seventh International Conference on Toxins, held in Berlin, Germany.
- Medtronic got approval from the Food and Drug Administration (FDA) in January 2024 for the PerceptTM RC neurostimulator that features BrainSenseTM technology. The device allows one to capture brain signals continuously, giving doctors real-time information that can be used to enhance therapy for movement disorders like spasticity.
Spasticity Treatment Key Market Trends
- Implementation of Minimally Invasive Procedures: In the management of spasticity, there has been an increased trend towards the use of less invasive treatment methods, including intrathecal medication infusion devices and botulinum toxin injections. Particularly with the localized type of spasticity, such treatment is extremely common among doctors as it provides temporary relief but with less pain and a shorter duration of recovery. This is particularly common in this situation.
- Application of Individualized Medical Care Treatment: The treatment paradigm for spasticity is changing on a large scale due to the rise of personalized medicine. Personalized drugs that are patient and gene profile-based are spreading rapidly. These drugs are more effective and less hazardous. Due to this spasticity treatment market trend, the outcomes of patients will further be improved, which will drive market growth.
Spasticity Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, due to the increasing incidence of neurological disorders and the increased number of studies being performed on treatments, the global spasticity treatment market is predicted to witness high growth. Two of the most significant growth drivers are the creation of customized treatments and utilization of minimally invasive therapeutic interventions. At the same time, there are limitations that could hinder widespread use, including the cost of therapy and adverse effects. Sustained innovation, better patient access, and increased awareness of all the many treatment modalities available are the three determinants of the industry's future.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 1.68 Billion |
| Market size value in 2032 | USD 2.44 Billion |
| Growth Rate | 8.02% |
| Base year | 2024 |
| Forecast period | 2025-2032 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Spasticity Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Spasticity Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Spasticity Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Spasticity Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Spasticity Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Spasticity Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
